The upregulation of VEGFC/D expression can promote tumor-associated lymphangiogenesis and increase tumor metastasis to local LNs and distant organs, which can be inhibited by blocking the binding of VEGFC/D to VEGFR-3 (18–20). The gene discussed is VEGFC; the disease is neoplasm.